Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (2): 402-404    DOI: 10.31083/j.ejgo.2021.02.2491
Commentary Previous articles |
SARS-CoV-2 vaccination in gynecologic oncology
Zachary Alholm1, *(), Daniel Spinosa2, Rebecca A. Previs3, Stephanie L. Shuey4, David M. O'Malley5, Leslie Randall6, Brian Slomovitz7, Bradley J. Monk8
1Department of Obstetrics and Gynecology, University of Arizona-Phoenix, Phoenix, AZ 85004, USA
2Department of Obstetrics and Gynecology, Duke University Health System, Durham, NC 27710, USA
3Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA
4Department of Pharmacy, Duke University Medical Center, Durham, NC 27710, USA
5Division of Gynecology Oncology, The Ohio State University and the James Comprehensive Cancer Center, Columbus, OH 43210, USA
6Division of Gynecologic Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23284, USA
7Division of Gynecology Oncology, Broward Health, Florida International University, Fort Lauderdale, FL 33199, USA
8Arizona Oncology (US Oncology Network), University of Arizona, Creighton University, Phoenix, AZ 85721, USA
Download:  PDF(161KB)  ( 103 ) Full text   ( 23 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
No abstract present.
Submitted:  13 April 2021      Accepted:  15 April 2021      Published:  15 April 2021     
*Corresponding Author(s):  Zachary Alholm     E-mail:  zalholm@gmail.com

Cite this article: 

Zachary Alholm, Daniel Spinosa, Rebecca A. Previs, Stephanie L. Shuey, David M. O'Malley, Leslie Randall, Brian Slomovitz, Bradley J. Monk. SARS-CoV-2 vaccination in gynecologic oncology. European Journal of Gynaecological Oncology, 2021, 42(2): 402-404.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.02.2491     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I2/402

No related articles found!
No Suggested Reading articles found!